LC16m8 mpox vaccine study in the DRC
Part of Infections clinical trials.
This study tests whether a single dose of the LC16m8 mpox vaccine is safe and works in people living in the Democratic Republic of Congo. It also monitors for side effects and tracks mpox cases to see how well the vaccine protects the community.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 12 months old or older.
- You must live in the study area in the Democratic Republic of Congo.
- You cannot have had a previous mpox vaccine.
- You cannot be pregnant or breastfeeding.
- You cannot have a spreading skin disease, a weak immune system, or an uncontrolled long-term illness.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new mRNA vaccine to prevent mpox. It looks at how safe and effective the vaccine is in adults who have or haven't been exposed to mpox or similar viruses before.
This study looks at the mpox outbreak in Equateur Province, Democratic Republic of Congo. It aims to understand who gets sick and how the virus spreads, which may help with future prevention.
This study is looking at people with mpox in the DR Congo to learn more about the outbreak. If you have a rash that fits the mpox pattern and a positive lab test, you may be able to join.
This study in West Africa follows people with confirmed mpox (monkeypox) infection and their close contacts to understand how the virus spreads, clears from the body, and how well the mpox vaccine protects people. You may be eligible if you've recently tested positive for mpox, were exposed to someone with mpox, or live in an area offering mpox vaccination.
This observational study looks at how your body’s defenses work against mpox (monkeypox), based on blood and health information. You may be eligible if you recently got an mpox vaccine or have had mpox infection and are now out of isolation.
This study looks at how well the mpox vaccine works during outbreaks. It tracks people who may have been exposed, those who have been vaccinated or already had mpox, and healthy volunteers.
Hear when a new Mpox (Monkeypox) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.